<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="3ab84078-2eec-46cd-9187-20ccaea44460"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Babe Didrikson Zaharias — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="19530427120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="8bbe6df9-d174-49e1-8bff-ec0e0bf1cd2f"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="28a8af85-15f8-4195-8a7d-9605dcdb53dc" extension="HR-ML038-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-38-4471"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Mildred</given><given>Ella</given><family>Didrikson Zaharias</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19110626"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="19530427120000-0500"/>
    <assignedAuthor><id root="128c0e69-c146-4de5-96e5-f3712cd841aa"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Vasquez-Thornbury</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="19530427120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="128c0e69-c146-4de5-96e5-f3712cd841aa"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Vasquez-Thornbury</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="19530427"/><high value="19530427"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="128c0e69-c146-4de5-96e5-f3712cd841aa"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Vasquez-Thornbury</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="10927aa2-9283-4662-b3c3-a9ec78134f4e"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Day 1 of cycle 2 of dostarlimab: early response, immune-related adverse event checks, germline and tumor genetic results, iron and anemia, and golf</originalText></code>
      <effectiveTime><low value="19530427"/><high value="19530427"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="128c0e69-c146-4de5-96e5-f3712cd841aa"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Vasquez-Thornbury</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Day 1 of cycle 2 of dostarlimab. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Didrikson Zaharias comes before her second dose of dostarlimab. The first dose three weeks ago caused no reaction. Within ten days the bleeding became occasional streaks, and for the last week there has been none; her stools are a normal shape and the urgency has eased. She has had no diarrhea, rash, cough, breathlessness, headache or thirst. She has taken ferrous sulfate every other morning for four weeks, with mild constipation that settled with more fruit, and she is less tired. She is practicing every day and played 18 holes twice last week. The germline panel was negative, and tumor sequencing found two changes in MSH2 in the tumor itself, which explains the mismatch repair deficiency. She asked what this means for her brothers and sisters. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Treatment</td><td>Dostarlimab cycle 1 three weeks ago; cycle 2 today</td></tr><tr><td>Symptoms</td><td>No bleeding for a week; normal stools; less tired</td></tr><tr><td>Adverse events</td><td>None</td></tr><tr><td>Genetic results</td><td>Germline panel negative; two somatic MSH2 variants in the tumor</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Negative</td><td>Energy better; no fever; weight 63.2 kg</td></tr><tr><td>Gastrointestinal</td><td>Negative</td><td>No bleeding for a week; no diarrhea or abdominal pain; mild constipation from iron, settled</td></tr><tr><td>Integumentary</td><td>Negative</td><td>No rash or itching</td></tr><tr><td>Respiratory</td><td>Negative</td><td>No cough or breathlessness</td></tr><tr><td>Endocrine</td><td>Negative</td><td>No heat or cold intolerance, thirst or headache</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Hopeful; PHQ-9 4; no thoughts of self-harm</td></tr></tbody></table><paragraph>6 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other morning</td><td>One tablet every other morning</td><td>Oral route</td><td>1953-03-30</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Dostarlimab-gxly 50 mg/mL injection, 500 mg intravenously over 30 minutes every 3 weeks, for nine doses (six months)</td><td>500 mg every 3 weeks for nine doses</td><td>Intravenous route</td><td>1953-04-06 to 1953-09-21</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="210cf611-4c76-4a29-b0b4-bd4435d339dd"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19530330"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="2" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="310325" codeSystem="2.16.840.1.113883.6.88" displayName="ferrous sulfate 325 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="a56b9f64-d0d6-47bf-ae43-b6ee43004d5f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="D50.0" codeSystem="2.16.840.1.113883.6.90" displayName="Iron deficiency anemia secondary to blood loss (chronic)"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="cf0a9228-3db9-4922-a0dc-a1360e47a076"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19530406"/><high value="19530921"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="21" unit="d"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="500" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2539972" codeSystem="2.16.840.1.113883.6.88" displayName="10 ML dostarlimab-gxly 50 MG/ML Injection"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="907caed6-b8dc-4782-bf2f-1bbee5ef13ef"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C20" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of rectum"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="879fc3c7-90d8-4f55-b18a-321eba99665f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19530316"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="1eb88946-aeb8-4b78-9281-6b3c7acd7ba1"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-3-1"><td>1953-04-27</td><td>Body height</td><td>168</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-3-2"><td>1953-04-27</td><td>Body weight</td><td>63.2</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-3-3"><td>1953-04-27</td><td>Body mass index (BMI) [Ratio]</td><td>22.4</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-3-4"><td>1953-04-27</td><td>Systolic blood pressure</td><td>110</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-5"><td>1953-04-27</td><td>Diastolic blood pressure</td><td>68</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-6"><td>1953-04-27</td><td>Heart rate</td><td>70</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-7"><td>1953-04-27</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-8"><td>1953-04-27</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-3-9"><td>1953-04-27</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>99</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="9fa0846e-bd19-49eb-b7bf-be4c06332e25"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="19530427"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="cc3127f7-c57d-4f8e-b127-82e68e3d0459"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-3-1"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="168" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="7583509a-98a2-44d8-9cf2-38a4c2a5d6bf"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-3-2"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="63.2" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ec5961f2-0cfa-419c-a258-78406929612e"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-3-3"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="22.4" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="08fedeba-4d8b-4e71-b728-4686b87ac69c"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-3-4"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="110" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="17c749d0-582f-40c2-8dd5-8df72e722c94"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-3-5"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="68" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1b40906c-46cc-4489-8ad5-a6b5a9f97de4"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-3-6"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="70" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="b230742a-f050-408d-8836-cb07471c4e7f"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-3-7"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="371854ff-8ac4-44d0-8cd2-fc1dc488affc"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-3-8"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="d9a9f935-9b35-4389-b696-746650e8c44e"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-3-9"/></text><statusCode code="completed"/><effectiveTime value="19530427"/><value xsi:type="PQ" value="99" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-30"><td>1953-04-27</td><td>Hemoglobin [Mass/volume] in Blood</td><td>12.1</td><td>g/dL</td><td>12-15.5 g/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-31"><td>1953-04-27</td><td>MCV [Entitic mean volume] in Red Blood Cells by Automated count</td><td>80</td><td>fL</td><td>80-100 fL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-32"><td>1953-04-27</td><td>Leukocytes [#/volume] in Blood by Automated count</td><td>6.2</td><td>10*3/uL</td><td>4-11 10*3/uL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-33"><td>1953-04-27</td><td>Platelets [#/volume] in Blood by Automated count</td><td>352</td><td>10*3/uL</td><td>150-400 10*3/uL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-34"><td>1953-04-27</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>0.74</td><td>mg/dL</td><td>0.59-1.04 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-35"><td>1953-04-27</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1948)/1.73 sq M</td><td>104</td><td>mL/min/{1.73_m2}</td><td>&gt;=60 mL/min/1.73 m²</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-36"><td>1953-04-27</td><td>Glucose [Mass/volume] in Serum or Plasma</td><td>92</td><td>mg/dL</td><td>70-99 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-37"><td>1953-04-27</td><td>Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>22</td><td>U/L</td><td>7-35 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-38"><td>1953-04-27</td><td>Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>24</td><td>U/L</td><td>8-35 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-39"><td>1953-04-27</td><td>Thyrotropin [Units/volume] in Serum or Plasma</td><td>2.2</td><td>m[IU]/L</td><td>0.45-4.5 mIU/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-40"><td>1953-04-27</td><td>Thyroxine (T4) free [Mass/volume] in Serum or Plasma</td><td>1.2</td><td>ng/dL</td><td>0.8-1.8 ng/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-41"><td>1953-04-27</td><td>Carcinoembryonic Ag [Mass/volume] in Serum or Plasma</td><td>3.4</td><td>ng/mL</td><td>Up to 3.0 ng/mL in non-smokers</td><td>High</td><td>S</td></tr>
  <tr ID="result-42"><td>1953-04-27</td><td>Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]</td><td>4</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3e7c2247-2e4b-4069-a665-eb6fd4e10ebc"/>
      <code code="58410-2" codeSystem="2.16.840.1.113883.6.1" displayName="CBC panel - Blood by Automated count"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19530427"/><high value="19530427"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="18b2bc09-d6bf-40f3-a947-07ff1709536c"/>
          <code code="718-7" codeSystem="2.16.840.1.113883.6.1" displayName="Hemoglobin [Mass/volume] in Blood"/>
          <text><reference value="#result-30"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="12.1" unit="g/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>12-15.5 g/dL</text>
              <value xsi:type="IVL_PQ"><low value="12" unit="g/dL"/><high value="15.5" unit="g/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="4bb08dce-c387-4324-ba93-cf3d4789c3e4"/>
          <code code="787-2" codeSystem="2.16.840.1.113883.6.1" displayName="MCV [Entitic mean volume] in Red Blood Cells by Automated count"/>
          <text><reference value="#result-31"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="80" unit="fL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>80-100 fL</text>
              <value xsi:type="IVL_PQ"><low value="80" unit="fL"/><high value="100" unit="fL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="6de9126b-fe79-4983-813c-bff54b2ad3de"/>
          <code code="6690-2" codeSystem="2.16.840.1.113883.6.1" displayName="Leukocytes [#/volume] in Blood by Automated count"/>
          <text><reference value="#result-32"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="6.2" unit="10*3/uL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>4-11 10*3/uL</text>
              <value xsi:type="IVL_PQ"><low value="4" unit="10*3/uL"/><high value="11" unit="10*3/uL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="f99eecad-fb67-48ce-af44-f7270441ea24"/>
          <code code="777-3" codeSystem="2.16.840.1.113883.6.1" displayName="Platelets [#/volume] in Blood by Automated count"/>
          <text><reference value="#result-33"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="352" unit="10*3/uL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>150-400 10*3/uL</text>
              <value xsi:type="IVL_PQ"><low value="150" unit="10*3/uL"/><high value="400" unit="10*3/uL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="bc0789c2-e790-422a-ba97-6dc554f3ad4f"/>
      <code code="24323-8" codeSystem="2.16.840.1.113883.6.1" displayName="Comprehensive metabolic 1927 panel - Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19530427"/><high value="19530427"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="116022e1-ce53-4df4-8fc3-d41d59c07298"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-34"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="0.74" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.59-1.04 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.59" unit="mg/dL"/><high value="1.04" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="3db99a40-aeb3-4358-9d59-f1a58d3e46fb"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-35"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="104" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&gt;=60 mL/min/1.73 m²</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="c4837166-6413-474a-830f-190391803c24"/>
          <code code="2345-7" codeSystem="2.16.840.1.113883.6.1" displayName="Glucose [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-36"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="92" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>70-99 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="70" unit="mg/dL"/><high value="99" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="5b10bf3f-4ba8-441a-a431-91cd8025274b"/>
          <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-37"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="22" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>7-35 U/L</text>
              <value xsi:type="IVL_PQ"><low value="7" unit="U/L"/><high value="35" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="6ef843f4-1a7d-4796-a7f6-7dedc097a808"/>
          <code code="1920-8" codeSystem="2.16.840.1.113883.6.1" displayName="Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-38"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="24" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>8-35 U/L</text>
              <value xsi:type="IVL_PQ"><low value="8" unit="U/L"/><high value="35" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="336613cb-a3f8-45d3-80c9-ac7fdb05d5e6"/>
      <code code="3016-3" codeSystem="2.16.840.1.113883.6.1" displayName="Thyrotropin [Units/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19530427"/><high value="19530427"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="7ce9466b-0538-465b-8c6c-821cf0b62ed2"/>
          <code code="3016-3" codeSystem="2.16.840.1.113883.6.1" displayName="Thyrotropin [Units/volume] in Serum or Plasma"/>
          <text><reference value="#result-39"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="2.2" unit="m[IU]/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.45-4.5 mIU/L</text>
              <value xsi:type="IVL_PQ"><low value="0.45" unit="m[IU]/L"/><high value="4.5" unit="m[IU]/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="24a22cef-2466-4e08-8a85-ff4a9be3ff24"/>
      <code code="3024-7" codeSystem="2.16.840.1.113883.6.1" displayName="Thyroxine (T4) free [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19530427"/><high value="19530427"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="2f8a5ca8-a6a7-4951-9472-f6f0cca269d1"/>
          <code code="3024-7" codeSystem="2.16.840.1.113883.6.1" displayName="Thyroxine (T4) free [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-40"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="1.2" unit="ng/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.8-1.8 ng/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.8" unit="ng/dL"/><high value="1.8" unit="ng/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3ecb5397-894b-44b6-9fb5-cab9faabc46d"/>
      <code code="2039-6" codeSystem="2.16.840.1.113883.6.1" displayName="Carcinoembryonic Ag [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19530427"/><high value="19530427"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="40098a35-196e-469f-a408-2aeaf23dd249"/>
          <code code="2039-6" codeSystem="2.16.840.1.113883.6.1" displayName="Carcinoembryonic Ag [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-41"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="3.4" unit="ng/mL"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>Up to 3.0 ng/mL in non-smokers</text>
              <value xsi:type="IVL_PQ"><high value="3" unit="ng/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="8c36e8dd-383c-4428-ac01-b443d62ac2fa"/>
      <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19530427"/><high value="19530427"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="24c87e72-36f8-4074-8957-de5296957ed0"/>
          <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
          <text><reference value="#result-42"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19530427"/>
          <value xsi:type="PQ" value="4" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1953-04-27; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; weight 63.2 kg; blood pressure 110/68, pulse 70</td></tr><tr><td>Skin</td><td>No rash</td></tr><tr><td>Neck</td><td>Thyroid not enlarged or tender</td></tr><tr><td>Abdomen</td><td>Soft, non-tender</td></tr><tr><td>Rectal</td><td>With her agreement and a chaperone: the mass is smaller and softer, with a flatter edge; no blood on the glove</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Bright red blood with bowel movements for about three months, with narrower stools, urgency, a feeling of incomplete emptying, and a firm, ulcerated mass felt on the back wall of the lower rectum at about 5 cm from the anal verge: a rectal cancer must be confirmed or excluded. Colonoscopy with biopsy booked this week</td><td>resolved</td><td>confirmed</td>
    <td>K62.5</td><td>S — Synthetic presenting problem anchored to the documented fatigue before her cancer diagnosis. Superseded by the diagnosis at the second visit.</td>
  </tr>
  <tr ID="problem-2">
    <td>Iron deficiency anemia from chronic rectal blood loss: hemoglobin 11.0 g/dL, MCV 77 fL, ferritin 9 ng/mL, with tiredness</td><td>active</td><td>confirmed</td>
    <td>D50.0</td><td>S — Synthetic finding anchored to the documented fatigue at the end of the 1952 season.</td>
  </tr>
  <tr ID="problem-3">
    <td>Adenocarcinoma of the low rectum, mismatch repair deficient (loss of MSH2 and MSH6; microsatellite instability high), cT3bN1M0 (stage IIIB) on pelvic MRI, lower edge 4 cm from the anal verge and about 1 cm above the anorectal junction, mesorectal fascia clear, no extramural venous invasion; CEA 5.8 ng/mL; synthetic modern detail linked to her documented cancer, whose site the sources do not record exactly</td><td>active</td><td>confirmed</td>
    <td>C20</td><td>S — Synthetic histology, site, stage, mismatch repair status and course; the sources say she had cancer treated with a colostomy and call it colon cancer (R on the site). See sources.md.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="bd205cde-b733-4455-9675-41ebff167857"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19530316"/><high value="19530330"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="a1f05052-ceee-4871-b6c4-c433c7223f9f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19530316"/><high value="19530330"/></effectiveTime>
          <value xsi:type="CD" code="K62.5" codeSystem="2.16.840.1.113883.6.90" displayName="Hemorrhage of anus and rectum"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="4f7ba24a-5e91-48d2-9ee0-c2ae4906965a"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19530316"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="e1bdee8d-e7f4-4d11-8778-e25b25d15652"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19530316"/></effectiveTime>
          <value xsi:type="CD" code="D50.0" codeSystem="2.16.840.1.113883.6.90" displayName="Iron deficiency anemia secondary to blood loss (chronic)"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="3b8cf412-1e6a-47ef-978f-b08a6743bd0a"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19530330"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="a0c849a6-f059-48fa-a31c-2dfa5edddf8a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19530330"/></effectiveTime>
          <value xsi:type="CD" code="C20" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of rectum"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Low rectal adenocarcinoma, mismatch repair deficient, on dostarlimab (C20)</content>. An early clinical response after one dose: the bleeding has stopped, the tumor is smaller to the finger, and CEA has fallen from 5.8 to 3.4 ng/mL. No immune-related adverse event; thyroid, liver and kidney tests normal. The germline panel found no pathogenic variant in MLH1, MSH2, MSH6, PMS2, EPCAM or the other colorectal cancer genes, and tumor sequencing found two somatic MSH2 variants, so this is a sporadic mismatch repair-deficient cancer rather than Lynch syndrome. Her first-degree relatives still have a raised risk because she had colorectal cancer young, and are advised to start colonoscopy at 40, or 10 years before her age at diagnosis if that is earlier, and repeat it every five years. Hepatitis B, hepatitis C and HIV tests were negative; hepatitis B surface antibody was negative, so vaccination is due. [S]<list><item>Dostarlimab cycle 2 today.</item><item>A letter for her to share with her brothers and sisters, if she chooses, explaining their screening.</item><item>Restaging MRI, sigmoidoscopy and examination after four doses.</item></list></item><item><content styleCode="Bold">Iron deficiency anemia from rectal blood loss (D50.0)</content>. Hemoglobin up from 11.1 to 12.1 g/dL and MCV from 77 to 80 fL four weeks after starting oral iron, with the bleeding stopped. [S]<list><item>Continue ferrous sulfate every other morning.</item><item>Ferritin at about three months.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>Blood count</td><td>Before each dose of dostarlimab and at each visit; about four weeks after oral iron starts</td><td>Completed today</td><td>Four weeks after oral iron: hemoglobin 12.1 g/dL, MCV 80 fL, white cells 6.2, platelets 352</td></tr><tr><td>Laboratory</td><td>Kidney and liver function and glucose</td><td>Before each dose of PD-1 blockade</td><td>Completed today</td><td>Creatinine 0.74 mg/dL, eGFR 104; ALT 22 U/L, AST 24 U/L; glucose 92 mg/dL</td></tr><tr><td>Laboratory</td><td>TSH and free T4</td><td>At baseline, then every six weeks on PD-1 blockade; six weeks after any levothyroxine change</td><td>Completed today</td><td>TSH 2.2 mIU/L, free T4 1.2 ng/dL</td></tr><tr><td>Laboratory</td><td>CEA</td><td>During treatment, as a marker of response</td><td>Completed today</td><td>3.4 ng/mL, down from 5.8</td></tr><tr><td>Examination</td><td>Digital rectal examination</td><td>At each oncology visit during treatment; every three to four months in watch-and-wait</td><td>Completed today</td><td>Mass smaller and softer; no blood</td></tr><tr><td>Examination</td><td>Immune-related adverse event review (diarrhea, rash, cough, breathlessness, fatigue, endocrine symptoms)</td><td>Before each dose</td><td>Completed today</td><td>None</td></tr><tr><td>Laboratory</td><td>Germline multigene panel and tumor sequencing</td><td>Germline result before treatment decisions that depend on it; tumor sequencing when the germline panel is negative</td><td>Completed today</td><td>Germline negative; two somatic MSH2 variants in the tumor; KRAS, NRAS and BRAF wild type</td></tr><tr><td>Self-management</td><td>Screening advice for first-degree relatives</td><td>Once the genetic results are known</td><td>Completed today</td><td>Colonoscopy from 40, or 10 years before her age at diagnosis if earlier, every five years; letter given for her to share as she chooses</td></tr><tr><td>Laboratory</td><td>Hepatitis B, hepatitis C and HIV screening</td><td>Before systemic cancer treatment</td><td>Up to date</td><td>All negative; hepatitis B surface antibody negative, so vaccination is due</td></tr><tr><td>Laboratory</td><td>Ferritin after oral iron</td><td>About three months after starting</td><td>Due</td><td>Due at the restaging visit</td></tr><tr><td>Imaging</td><td>Restaging pelvic MRI and flexible sigmoidoscopy</td><td>About every three months during treatment</td><td>Due</td><td>Booked for the week before cycle 5</td></tr><tr><td>Survey</td><td>Distress and depression screen (PHQ-9, GAD-7)</td><td>At diagnosis, at each treatment phase, and at least yearly</td><td>Completed today</td><td>PHQ-9 4; item 9 scored 0</td></tr><tr><td>Self-management</td><td>Physical activity and sport</td><td>Each visit</td><td>Completed today</td><td>Playing 18 holes and practicing daily</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Colonoscopy within one week, staging within two weeks, and a tumor board plan before treatment. Outcome by 1953-03-30: Colonoscopy in three days, MRI and CT within nine days, tumor board in eleven days, consultation at two weeks [S]</item><item>Germline genetic testing with counseling, and an explanation of the mismatch repair deficiency, within four weeks of diagnosis. Outcome by 1953-04-27: Germline panel negative; two somatic MSH2 variants in the tumor explain the deficiency [S]</item><item>Clinical complete response after six months of dostarlimab, with the rectum and sphincter preserved. In progress; target 1953-10-05 [S]</item><item>Hemoglobin of 12 g/dL or more and ferritin above 30 ng/mL. In progress; target 1953-10-05 [S]</item><item>Back to tournament golf during treatment. In progress; target 1953-06-29 [S]</item><item>TSH within the reference range on thyroid replacement. In progress; target 1953-08-10 [S]</item><item>PHQ-9 below 10 throughout treatment. In progress; target 1953-10-05 [S]</item></list><paragraph>Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer (current version); summarized in Benson AB, et al. NCCN Guidelines Insights: Rectal Cancer, Version 3.2024. J Natl Compr Canc Netw 2024;22(6):366-375 (PMID 39151454) (2026); Cercek A, et al. PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer. N Engl J Med 2022;386(25):2363-2376 (PMID 35660797) (2022); Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021;39(36):4073-4126 (PMID 34724392) (2021); Tung N, et al. Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline. J Clin Oncol 2024;42(21):2599-2615 (PMID 38759122) (2024); Rex DK, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2017;112(7):1016-1030 (PMID 28555630) (2017); CMID: Clinical Monitoring Intelligence Database, colorectal cancer, hypothyroidism and anemia monographs (2026)</paragraph><paragraph>Follow-up: Cycles 3 and 4 as booked; restaging MRI and sigmoidoscopy in about eight weeks; primary care review at cycle 5. Next scheduled visit 1953-06-29: restaging after four doses: pelvic MRI and endoscopy, immune-related hypothyroidism, and the decision to continue PD-1 blockade. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
